BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20975424)

  • 21. Ethnic differences in responses to disease modifying drugs.
    Helliwell PS; Ibrahim G
    Rheumatology (Oxford); 2003 Oct; 42(10):1197-201. PubMed ID: 12810940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Individual and interdisciplinary treatment of rheumatic diseases in pregnancy].
    Bolz M
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2415. PubMed ID: 18988135
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tolerance of anti-TNF alpha: the experience acquired in inflammatory rheumatic disease].
    Mariette X
    Ann Dermatol Venereol; 2006 May; 133(5 Pt 2):1S8-12. PubMed ID: 16967603
    [No Abstract]   [Full Text] [Related]  

  • 24. Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide.
    Metzler C; Arlt AC; Gross WL; Brandt J
    Ann Rheum Dis; 2005 Dec; 64(12):1798-800. PubMed ID: 16284351
    [No Abstract]   [Full Text] [Related]  

  • 25. Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologist.
    Pincus T; Braun J; Kavanaugh A; Smolen JS
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S1-3. PubMed ID: 24129127
    [No Abstract]   [Full Text] [Related]  

  • 26. Pediatric rheumatic disease: Vaccination in pediatric rheumatic disease--risks and benefits.
    Janow G; Ilowite NT
    Nat Rev Rheumatol; 2012 Feb; 8(4):188-90. PubMed ID: 22331060
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rheumatic diseases during pregnancy].
    Fischer-Betz R
    Internist (Berl); 2012 Sep; 53(9):1047-53. PubMed ID: 22695896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse drug reactions and their measurement in the rheumatic diseases.
    Day RO; Quinn DI; Conaghan PG; Tett SE
    J Rheumatol; 1995 May; 22(5):983-8. PubMed ID: 8587095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Safety of rheumatic disease drugs at childbearing age].
    Zrour-Hassen S; Jguirim M; Aouam K; Korbaa W; Younes M; Bejia I; Touzi M; Bergaoui N
    Therapie; 2010; 65(5):465-73. PubMed ID: 21144482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients: Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors.
    Betancourt BY; Biehl A; Katz JD; Subedi A
    Rheum Dis Clin North Am; 2018 Aug; 44(3):371-391. PubMed ID: 30001781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection prophylaxis in antirheumatic therapy: emphasis on vaccination.
    Kavanaugh A
    Curr Opin Rheumatol; 2009 Jul; 21(4):419-24. PubMed ID: 19444117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs in pregnancy. Rheumatological disorders.
    Østensen M
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):953-69. PubMed ID: 11800535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.
    Monach PA; Arnold LM; Merkel PA
    Arthritis Rheum; 2010 Jan; 62(1):9-21. PubMed ID: 20039416
    [No Abstract]   [Full Text] [Related]  

  • 34. Tuberculosis associated with therapy against tumor necrosis factor alpha.
    Winthrop KL; Siegel JN; Jereb J; Taylor Z; Iademarco MF
    Arthritis Rheum; 2005 Oct; 52(10):2968-74. PubMed ID: 16200576
    [No Abstract]   [Full Text] [Related]  

  • 35. Antirheumatic drugs in pregnancy and lactation.
    Temprano KK; Bandlamudi R; Moore TL
    Semin Arthritis Rheum; 2005 Oct; 35(2):112-21. PubMed ID: 16194696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection and anti-tumor necrosis factor-alpha therapy.
    Zandman-Goddard G
    Isr Med Assoc J; 2003 Nov; 5(11):814-6. PubMed ID: 14650109
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical immunotoxicity of antirheumatic drugs.
    Bálint G; Gergely P
    Inflamm Res; 1996 Dec; 45 Suppl 2():S91-5. PubMed ID: 8988409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refining drug safety in rheumatology.
    Cush JJ; Dao KH
    Rheum Dis Clin North Am; 2012 Nov; 38(4):xi-xiv. PubMed ID: 23137585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intracellular therapeutic procedures].
    Müller-Ladner U; Neumann E
    Z Rheumatol; 2012 Aug; 71(6):459. PubMed ID: 22802022
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evidence based medicine in rheumatology].
    Gause A; Raspe HH
    Z Rheumatol; 2002 Oct; 61(5):516-8. PubMed ID: 12399877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.